Want to see TSE:ASTI full AI Analyst Report?

Aquarius Surgical Technologies (ASTI) Price & Analysis

1 Followers

ASTI Stock Chart & Stats

C$0.02

C$0.00(0.00%)

At close: Jun 22 4:00 PM EDT

C$0.02

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.01 - C$0.02

Previous CloseN/A

Volume10.50K

Average Volume (3M)2.11K

Market Cap

C$275.99K

Enterprise ValueC$7.30M

Total Cash (Recent Filing)C$47.66K

Total Debt (Recent Filing)C$7.07M

Price to Earnings (P/E)―

Beta-0.19

Next Earnings

Dec 02, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.05

Shares Outstanding27,599,173

10 Day Avg. Volume0

30 Day Avg. Volume2,110

Financial Highlights & Ratios

PEG Ratio0.01

Price to Book (P/B)-0.06

Price to Sales (P/S)4.53

P/FCF Ratio-3.56

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue ReboundThe 20.3% TTM revenue rebound indicates that the company has regained some commercial momentum and may be reaching more customers or generating greater demand. Continued top-line recovery would improve operating leverage and provide a larger base from which to absorb fixed costs.

Gross MarginA TTM gross margin of about 44% suggests the underlying products generate meaningful gross profit before operating expenses and non-operating costs. This provides a potentially workable foundation for improvement if management can control expenses and scale revenue without eroding product economics.

Reduced Cash BurnThe smaller TTM cash burn compared with 2025 represents a modest improvement in cash consumption. Although cash generation remains negative, reducing the pace of outflows could extend financial runway and give the company more time to improve operations or secure funding.

Bears Say

Stressed Balance SheetNegative equity combined with debt substantially exceeding total assets creates a structurally weak capital base. This reduces financial flexibility, increases refinancing pressure, and raises the likelihood that future funding could involve dilution or unfavorable financing terms.

Severe UnprofitabilityThe extremely negative net margin and continuing EBIT and EBITDA losses show that the business is not covering its cost base through operations. Persistent losses can consume capital, limit reinvestment capacity, and make future growth dependent on a successful turnaround in profitability.

Negative Cash GenerationNegative operating and free cash flow indicate that current activities are not consistently funding the business. Continued cash deficits can constrain investment and operations, while reliance on external funding increases exposure to financing availability and potential dilution.

ASTI FAQ

What was Aquarius Surgical Technologies Inc.’s price range in the past 12 months?

Aquarius Surgical Technologies Inc. lowest stock price was C$0.01 and its highest was C$0.02 in the past 12 months.

What is Aquarius Surgical Technologies Inc.’s market cap?

Aquarius Surgical Technologies Inc.’s market cap is C$275.99K.

When is Aquarius Surgical Technologies Inc.’s upcoming earnings report date?

Aquarius Surgical Technologies Inc.’s upcoming earnings report date is Dec 02, 2026 which is in 50 days.

How were Aquarius Surgical Technologies Inc.’s earnings last quarter?

Aquarius Surgical Technologies Inc. released its earnings results on Jul 27, 2026. The company reported -C$0.006 earnings per share for the quarter.

Is Aquarius Surgical Technologies Inc. overvalued?

According to Wall Street analysts Aquarius Surgical Technologies Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aquarius Surgical Technologies Inc. pay dividends?

Aquarius Surgical Technologies Inc. does not currently pay dividends.

What is Aquarius Surgical Technologies Inc.’s EPS estimate?

Aquarius Surgical Technologies Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aquarius Surgical Technologies Inc. have?

Aquarius Surgical Technologies Inc. has 27,599,173 shares outstanding.

What happened to Aquarius Surgical Technologies Inc.’s price movement after its last earnings report?

Aquarius Surgical Technologies Inc. reported an EPS of -C$0.006 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Aquarius Surgical Technologies Inc.?

Currently, no hedge funds are holding shares in TSE:ASTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aquarius Surgical Technologies Inc.

Aquarius Surgical Technologies Inc., operating through its subsidiary Surgical Lasers Inc., specializes in the creation, sale, distribution, and promotion of advanced technological solutions tailored for surgical and other healthcare settings throughout Canada and the United States. The company's core offering comprises sophisticated medical laser systems, catering to a diverse array of specialties such as urology, gynecology, ophthalmology, thoracic surgery, otolaryngology (ENT), cardiovascular procedures, and neurosurgery. Incorporated in 1986, the Toronto, Canada-based firm was previously known as Aquarius Coatings Inc.